<DOC>
	<DOCNO>NCT02514499</DOCNO>
	<brief_summary>The overall goal propose research evaluate uptake test longitudinal risk benefit multiplex test cancer susceptibility BRCA1/2 negative patient . This model inform selection outcomes potential mediator moderator outcomes , inform debate utility , risk , benefit clinical incorporation multiplex test breast cancer susceptibility .</brief_summary>
	<brief_title>Multiplex Testing Evaluation Breast Cancer Risk , Longitudinal Study</brief_title>
	<detailed_description />
	<criteria>1 . Women men ( least 18 YO ) 2 . English speaking AND 3 . Negative BRCA1 BRCA2 mutation 1 . Non English speaking patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>patient</keyword>
</DOC>